PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10722230-4	2000	In the peripheral blood of newly diagnosed Graves" disease patients we showed a significant decrease of gammadelta TCR+ cells and gammadelta TCR+CD8- subset content in comparison to the percentages observed in subjects after methimazole treatment and in healthy controls.	Methimazole	225-236	CD8a molecule	Homo sapiens	145-148	
24364474-0	2013	Impact of treatment with methimazole on the Bcl-2 expression in CD8+ peripheral blood lymphocytes in children with Graves" disease.	Methimazole	25-36	CD8a molecule	Homo sapiens	64-67	
34970859-10	2022	High levels of senescent CD8+ T cells at Week 0 were significantly associated with small increases in handgrip strength after 12 weeks of methimazole treatment (P < 0.05), but not statistically associated with Five Times Sit to Stand Test performance.	Methimazole	138-149	CD8a molecule	Homo sapiens	25-28